New York State Common Retirement Fund’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Hold |
9,797
| – | – | ﹤0.01% | 2260 |
|
|
2025
Q1 | $193K | Sell |
9,797
-15,226
| -61% | -$300K | ﹤0.01% | 2246 |
|
|
2024
Q4 | $563K | Sell |
25,023
-2,488
| -9% | -$56K | ﹤0.01% | 1903 |
|
|
2024
Q3 | $703K | Buy |
27,511
+4,341
| +19% | +$111K | ﹤0.01% | 1808 |
|
|
2024
Q2 | $541K | Buy |
23,170
+13,795
| +147% | +$322K | ﹤0.01% | 2015 |
|
|
2024
Q1 | $165K | Sell |
9,375
-24
| -0.3% | -$422 | ﹤0.01% | 2533 |
|
|
2023
Q4 | $130K | Sell |
9,399
-54
| -0.6% | -$747 | ﹤0.01% | 2636 |
|
|
2023
Q3 | $129K | Buy |
9,453
+253
| +3% | +$3.45K | ﹤0.01% | 2615 |
|
|
2023
Q2 | $188K | Buy |
+9,200
| New | +$188K | ﹤0.01% | 2526 |
|
|
2021
Q3 | – | Sell |
-16
| Closed | -$1K | – | 3390 |
|
|
2021
Q2 | $1K | Sell |
16
-1,584
| -99% | -$99K | ﹤0.01% | 3393 |
|
|
2021
Q1 | $54K | Hold |
1,600
| – | – | ﹤0.01% | 3200 |
|
|
2020
Q4 | $141K | Buy |
1,600
+475
| +42% | +$41.9K | ﹤0.01% | 2884 |
|
|
2020
Q3 | $92K | Hold |
1,125
| – | – | ﹤0.01% | 2953 |
|
|
2020
Q2 | $124K | Buy |
+1,125
| New | +$124K | ﹤0.01% | 2848 |
|